Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajd.13324 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association between adolescent obesity and early adulthood healthcare utilization-a two-cohort prospective study.
BMC Med
January 2025
Department of Surgery, Obesity Research Centre, St. Olavs Hospital Trondheim University Hospital, Trondheim, Norway.
Background: Pediatric obesity is a growing global health challenge, with long-term implications for individuals and healthcare systems. Existing studies on the association between pediatric obesity and healthcare use in adulthood are limited and often rely on mathematical simulation models. This study aims to provide real-world data on the impact of adolescent obesity on specialized healthcare utilization and costs in early adulthood.
View Article and Find Full Text PDFUltrasound-guided peripheral intravenous access in adults: A randomized crossover controlled trial.
Int Emerg Nurs
January 2025
Nursing Department, Chi-Mei Medical Center, Taiwan; Department of Senior Welfare and Services, Southern Taiwan University of Science and Technology, Taiwan. Electronic address:
Background: Peripheral intravenous access is a common invasive clinical procedure, and difficult peripheral intravenous access is a common problem in the care of emergency and critically ill patients. The timeliness of immediate treatment is affected by the difficulty of intravenous access in clinical practice, which endangers patient safety. Repeated injections increase the pressure on nursing staff, consume more nursing hours, and incur higher medical costs.
View Article and Find Full Text PDFHigh Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis.
Thyroid
January 2025
Division of Endocrine Surgery, Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong.
Cytologically indeterminate thyroid nodules (Bethesda class III or IV) carry a 10-40% risk of malignancy. Diagnostic lobectomies are frequently performed but negative surgeries incur unnecessary costs on the healthcare system, potential complications, and negative impacts on quality of life. Molecular tests (MTs) have been developed to reduce unnecessary surgeries.
View Article and Find Full Text PDFPoint-of-care testing of methotrexate using a controlled release sensor based on a personal glucose meter.
Anal Methods
January 2025
Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, PR China.
Methotrexate (MTX), a widely administered medication for treating an array of tumors and autoimmune disorders, necessitates stringent monitoring due to the potential for severe adverse effects associated with its high dosage. Nevertheless, the existing methods for monitoring MTX are often intricate, time-consuming and incur significant costs. In this work, we constructed a controlled release sensor, harnessing the versatility of a personal glucose meter (PGM), which had been devised for the swift detection of MTX.
View Article and Find Full Text PDFCost-Utility Analysis of Erenumab Compared to Topiramate for Preventive Therapy of Migraine in Iran.
Iran J Pharm Res
September 2024
Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Background: Migraine is a prevalent, chronic neurovascular disorder that incurs significant indirect costs due to productivity loss. Preventive therapy is an effective way to alleviate the societal and healthcare burden of migraine. Approximately 14% of both the global and Iranian populations are affected by migraine, which has substantial economic implications.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!